Tagmokitug (CHS-114) is a fully human IgG1 antibody that targets CCR8. Tagmokitug has the potential for the study of head and neck squamous cell carcinoma (HNSCC). The isotype control for Tagmokitug can refer to Human IgG1 lambda2, Isotype Control (HY-P990096)[1].
Molecular Weight:
(144.12 kDa)
Purity:
99.9
CAS Number:
[3024486-14-1]
Target:
CCR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted